FEV Group: FEV develops AI-supported driver monitoring system CogniSafe
9.1.2025 11:05:03 CET | news aktuell GmbH | Press release
Aachen – FEV, a leading global innovation driver for the mobility of tomorrow, presents CogniSafe, a state-of-the-art Driver Monitoring System (DMS) that significantly increases road safety. The system uses advanced technologies such as deep learning and computer vision to monitor driver conditions such as distraction, fatigue and inattention in real time and under even the most challenging conditions.

“CogniSafe is a holistic, innovative system that uses a variety of sensors and combines them with artificial intelligence (AI) to precisely analyze driver behavior and alertness”, said Dr. Thomas Hülshorst, Group Vice President Intelligent Mobility & Software at FEV. In (semi-) autonomous vehicles in particular, legal safety requirements are increasing, and the driver must be able to intervene in any situation. “With our latest development, we are actively reducing accidents caused by human error. At over 90 percent, these make up the majority of all accidents,” said Hülshorst.
CogniSafe uses a combination of functions which are unique on the market and coordinate with each other. It uses a network of cameras in the visible light and infrared spectrum to analyze driver behavior from different angles. On this basis, the system continuously tracks the driver's gaze, analyzes eye condition (percentage of eye closure, PERCLOS) and assesses head posture, providing further information on alertness, fatigue and drowsiness.
AI plays a pivotal role in the functions of FEV's latest development. Convolutional Neural Networks (CNN) are used to perform precise real-time analyses that dynamically adapt to different drivers and environmental conditions, such as different lighting conditions, and continuously improve.
“The solution is also very interesting for target groups such as fleet operators or insurance companies, who have a strong interest in safe driving practices”, said Hülshorst.
Further information is available at https://shorturl.at/hy3dq
Marius Strasdat
T +49 241 5689-6452
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:39:09 CET | Press release
Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.
Valle Venia presents new song by LPS feat. Lara: Where will it take me27.2.2026 10:15:00 CET | Press release
The song describes the challenge of trusting the flow, relying on oneself, following one's own values with confidence.
Vyoma awarded ESA data procurement contract for space-based data on small space debris24.2.2026 10:53:34 CET | Press release
(Munich, February 24th, 2026) Vyoma, a Munich-based company providing Space Domain Awareness (SDA) capabilities, has been selected as the winner of the ESA tender on ”Data Procurement for Space-Based Statistical Data on Small Space Debris Phase 1”, funded via ESA‘s Space Safety Programme (S2P). ESA’s Meteoroid And Space debris Terrestrial Environment Reference (MASTER) model provides a description of the space environment around Earth, supporting satellite designers, operators and others with risk assessments. Currently, there exists a significant temporal and spatial knowledge gap for observations of space debris with sizes smaller than the detection limit of ground-based sensors. Vyoma's Flamingo-1 satellite is ideally positioned to generate the image data ESA is seeking. Flying “in-situ” at an altitude of 510 km, Flamingo-1's instrument can monitor large volumes of space at once. This sensor detects objects at long and short distances and captures small and fast objects reliably, im
Medi-Globe Launches mAI Companion® — the World’s First Real Time AI Assistant for Pancreatic EUS, Co Developed with IHU Strasbourg —Now MDR CE Marked and Available for Clinical Use in Europe24.2.2026 10:00:00 CET | Press release
Rohrdorf (Achenmühle), Germany — February 24, 2026 — Medi-Globe today announced the launch of mAI Companion®, a real-time medical AI solution designed to assist physicians in detecting pancreatic lesions during endoscopic ultrasound (EUS) — addressing one of the deadliest and most difficult-to-detect cancers, where earlier identification can dramatically change patient outcomes.
Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect24.2.2026 08:43:52 CET | Press release
Aachen, Germany & Victoria, Australia, 24 February 2026 – Grünenthal, a global leader in pain management and related diseases, and Clinect Pty Ltd ("Clinect"), an Australian based company focussed on supporting access to unique products, announced today that they have entered into a definitive agreement whereby Clinect will have the exclusive Australian rights to Qutenza®, a topical, non-systemic, non-opioid patch indicated for the management of peripheral neuropathic pain. Under the agreement, Clinect will be responsible for obtaining marketing authorisation for Qutenza® in Australia and, upon approval, marketing and distributing the product in Australia.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom